A-Alpha Bio is a startup based in the United States, 1 tracked investor.
Based in the United States, A-Alpha Bio is a startup. Brouky records 1 investor associated with the company.
A-Alpha Bio is a biotechnology company that uses synthetic biology and machine learning to measure, predict, and engineer protein–protein interactions. Its AlphaSeq platform employs genetically engineered cells to experimentally measure millions of protein–protein interaction affinities at library-on-library scale to support therapeutic discovery.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.